GlassScriptPhysician profile
Rubin Brecher
NPI 1609842749
$2,594.51
in general payments reported to CMS, 2019-2025
16 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $66.37 · 2021: $502 · 2022: $199 · 2023: $560 · 2024: $368 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $710.14 | 2021-2025 | Eylea Hd, Eylea |
| Aerie Pharmaceuticals, INC. | $530.35 | 2019-2021 | |
| Alcon Vision LLC | $297.71 | 2022-2025 | Rocklatan, Simbrinza, Rhopressa |
| Oyster Point Pharma, INC. | $226.37 | 2022-2024 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $168.01 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $155.73 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.13 | 2019 | |
| Allergan, INC. | $98.18 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $55.62 | 2025 | Xdemvy |
| Astellas Pharma US INC | $54.91 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $54.45 | 2019-2025 | |
| Harrow Eye, LLC | $24.89 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $23.15 | 2021 | |
| Recordati_rare_diseases_inc. | $21.98 | 2023 | Cystadrops |
| Dompe US, INC. | $18.98 | 2025 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $18.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rubin Brecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.